FDA Import Refusal UPS-7478571-9/11/1 — Janssen Pharmaceuticals, Inc
The FDA refused shipment UPS-7478571-9/11/1 from Janssen Pharmaceuticals, Inc (United States) on Mar 9, 2018. The refused product falls under Drugs and Biologics — INFLIXIMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 9, 2018
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61YCP01 INFLIXIMAB
- Charges
- 75